COVID-19 PANDEMIC UPDATE: This program will next enroll students for the Fall 2022 trimester. This program will be delivered in its standard online format for students entering the program in the Fall 2022 trimester; the program can be completed by taking only online classes, and there are no requirements to come to campus.
The Post-Baccalaureate Certificate in Cannabis Science: Therapeutics, Product Design, and Quality Assurance is one of the few graduate programs in the U.S. to focus on cannabis and to support this rapidly growing industry. The program educates students about cannabis-based products with an emphasis on health effects, safety, formulation, and quality assurance. The program addresses CBD-dominant hemp-based dietary supplements and wellness products, as well as THC-dominant medical and recreational marijuana. The program is 15 credits, can be completed in 1 year, and is delivered fully online.
This program is designed for individuals who wish to approach the cannabis field through the primary lenses of herbal medicine and health and wellness. It is designed for individuals who wish to promote evidence-informed, safe, and responsible use of high-quality cannabis-based products, especially those with holistic approach and a focus on a health promotion model rather than a disease management model. The program is ideal for career starters and those seeking an initial career in the industry or looking to expand their job options within the field. The program is also designed for integrative health and conventional practitioners interested in learning about the industry in order to be informed for their clients.
The Post-Baccalaureate Certificate in Cannabis Science: Therapeutics, Product Design, and Quality Assurance educates students about products with an emphasis on health effects, safety, formulation, and quality assurance. The program integrates the science of herbal medicine and evidence-informed research needed to develop innovative strategies for commercializing safe and effective products. Unique to this program, students will investigate ways to combine cannabis with other herbs to optimize health benefits and reduce risks.
The program provides education in the following areas:
This is a non-experiential program. There are no internships, laboratories, field work, or hands on work with cannabis as part of this curriculum and program.
This field can be approached and viewed through a variety of lenses. MUIH’s program approaches cannabis through two primary lenses: 1) health and wellness, and 2) herbal medicine.
Health and Wellness Focus
MUIH’s program and courses emphasize non-medical, CBD-dominant types of medicine. These federally legal, non-psychoactive forms of cannabis are increasingly incorporated into health and wellness models of care. Such models are less focused on disease management and more focused on supporting health-positive constructs such as resilience and well-being. This health and wellness focus is consistent throughout all of MUIH’s programs and distinguishes them from more conventional healthcare programs. The program also considers to a lesser extent, medical cannabis, which is used within a conventional healthcare model to help treat and manage disease.
Herbal Medicine Focus
Cannabis is discussed within the broad context of herbal medicine as a whole. Two key aspects of traditional herbal medicine are incorporated into the program. First, herbs are not typically used alone and are mostly used as part of combination formulas. While it may be the central herb addressed in this program, there will be a continual discussion and consideration of other herbs that can be combined to potentially enhance benefits and reduce risk. Second, herbal medicine emphasizes different categories of herbs and clinical approaches for “compensation” (support during illness and dysfunction) and “enhancement” (support for building and maintaining healthy function). This offers an additional lens through which to view cannabis and provides further contrast between MUIH’s health and wellness model and conventional medical models.
The program builds on MUIH’s 20 years of experience offering herbal medicine programs. It is one of the very few accredited universities in the U.S. to offer graduate programs in the field. MUIH has delivered master’s programs in herbal medicine since 2002, when it launched the first master’s degree in herbal medicine in the United States. The faculty in herbal medicine understand cannabis as one of many therapeutic plants and this perspective will permeate all aspects of the program. The program faculty are uniquely qualified to discuss cannabis within the framework of herbal medicine principles and practices, something quite distinct from a conventional medical or pharmaceutical perspective.
The program applies theory to practice in its herbal medicine dispensary. MUIH has operated an herbal medicine dispensary since 2002. It has served as an educational setting for herbal medicine dispensary practices and quality assurance while providing herbal products to healthcare professionals, herbal medicine students, and the general public. The standards and practices from its herbal medicine dispensary, generalizable to working with a range of herbs for various health and wellness purposes in various settings, are leveraged to inform the program and its courses. This dispensary does not work with any CBD based products and it is not a medical dispensary. The courses in this program emphasize herbal dispensary practices and quality assurance for federally legal, non-psychoactive, CBD-dominant products and herbal products in general.
The program includes a scientific exploration of two distinct sets of products. The first group is the CBD-dominant hemp-based products that are not psychoactive, are legal in all fifty U.S. states, and are being integrated increasingly into the dietary supplement industry. The second set of products are medical and recreational THC-dominant products that are psychoactive, regulated more strictly than hemp-based products, and mostly available through a limited number of licensed dispensaries. The program examines the science and explores the evidence for therapeutic benefits and risks, and considerations in product design for both types of products. Discussion of dispensary practices and quality assurance emphasize CBD-dominant hemp-based products.
With regards to CBD-dominant hemp-based products, students including complementary and integrative health (CIH) practitioners will learn how to assess products on the market and safely and appropriately recommend those that are well-designed and meet quality control standards. Students interested in product design or other work in the dietary supplement industry, will learn the principles of formulation and quality assurance for purposes of evaluating existing products and product development.
Recommending THC-dominant products does not fall within the scope of practice for most CIH practitioners; however, many clients are consuming or considering consuming THC-dominant products. It is important that CIH practitioners be well informed about quality, safety, and effectiveness of THC-dominant products in order to identify safety concerns as well as refer to other clinicians when appropriate. Students interested in working in licensed dispensaries will also benefit from this education as it provides them with the tools to evaluate retail products, build general quality control practices into the dispensary workflow, and inform customers about available products in an ethical and responsible fashion.
This program is designed to serve students with and without a background in science or medicine. Courses are designed to scaffold learning, knowledge, and skills in ways that meet students’ prior educational levels in the sciences. Courses and instruction are also designed to respect and incorporate students’ workplace experiences, and to build upon them and enrich the course for others. This is an intentional design element for all of MUIH’s programs, in which pre-requisite knowledge, skills, and courses are built into the first-year curriculum of all programs, and with very few exceptions no prerequisite knowledge or credentials in the field are required for admission to MUIH’s programs. MUIH’s other science-based graduate programs in herbal medicine routinely admit new students with little to no experience in these fields, and the prerequisite science knowledge and skills are imparted through specific courses or basic concepts intentionally woven through the curriculum. This design element is consistent to MUIH’s overall philosophy of curriculum design.
The Post-Baccalaureate Certificate in Cannabis Science is a graduate program, which differs from training programs offered in the field. Through this graduate-level academic program students will also gain the foundational skills that employers seek and that can establish them as leaders in their field, and which are not typically provided by non-credit training programs. This includes skills such as critical thinking, problem solving, and research literacy. Click here for a description of the added value of a graduate program.
|Trimester of Entry:||Fall, Spring|
|Application Priority Deadline:||Application deadline by Trimester|
|Program Specific Requirements:||Complete Essay Questions in application:
The program consists of 15 credits of the following required courses:
Upon completion of the program graduates will be able to:
This program is offered in the online format. Click here to view MUIH’s definition of the online program format.
For trimester start and end dates, see the Academic Calendar.
The schedule of courses for this program is shown below:
|Course Code||Cost per Credit||# of Credits||Tuition Cost*|
*Prices subject to change. Tuition costs are for illustrative purposes only.
|Average Credits per Trimester||Typical Completion Time|
|Non-Refundable Tuition Deposit||$150|
|University Fee (per trimester)||$275
All students, including students taking a voluntary break in enrollment. Click here to learn more about the fee.
|Late Registration Fee
After registration deadline and before start of the schedule adjustment period for current students$150/course
During the schedule adjustment period for current and new students who have confirmed before the late confirmed student registration period begins
|Cooking Lab Fee||NUTR 681 – $40/course
NUTR 682 – $40/course
NUTR 683 – $45/course
NUTR 684 – $45/course
NUTR 686 – $30/course
NUTR 687 – $40/course
NUTR 688 – $40/course
|Cooking Kit Fee||$225
M.S. in Nutrition and Integrative Health students (1st trimester) and other students taking cooking labs (NUTR 681 – 689)
|Herb Kit Fee||Students enrolled in the following herbal medicine courses:
HRB 605 $160
HRB 614 $185
HRB 622 $150
HRB 642 $220
HRB 653 $85
HRB 705 $180
Due to international customs requirements, we do not ship herb kits outside of the United States
HRB 636 $175
|Credit Card Adjustment Fee||2.75% of amount paid by credit card|
The cannabis industry is made up of three fields – 1) medical marijuana, 2) recreational marijuana, and 3) hemp-based, CBD-dominant cannabis. Each has experienced and is projected to have continued significant growth. The increase in use and sales of cannabis nationally is driving significant job growth in the field.
Legalization and Use
As of January 2020, medical and recreational marijuana is legal in 11 states, medical marijuana only is legal in 22 states, and hemp is federally legal in all 50 states (1, 2). The 2017 National Survey on Drug Use and Health estimated that 24 million Americans above the age of 18 were users of marijuana, representing nearly 9% of the total population; marijuana use among the same group increased from 21% in 2002 to 30% in 2017 (3).
Overall Cannabis Industry Growth
New Frontier Data reports overall sales within the legalized U.S. cannabis industry, which includes both recreational and medical marijuana, were expected to reach $13.6 billion throughout 2019, a 32% increase over 2018 sales (4). Forty months after its launch in 2017, Maryland’s cannabis market reached $1 billion in sales (16). Total combined U.S. legal sales are projected to continue to grow at an annual rate of 14%, reaching $30 billion in sales by 2025. Total legal recreational use sales are projected to grow 16% to $16.6 billion in sales by 2025. If the total U.S. cannabis market were to be legalized, Barclay’s (5) estimates the market could be worth $41 billion by 2028, and Cowen and Company estimates a market value of $80 billion by 2030 (6). Globally, Fortune Business Insights reports the cannabis market (including medical, recreational and hemp-based) was $10.6 billion in 2018 and projects it to reach $97.3 billion by the end of 2026, a 33% annual growth from 2019 to 2026 (7).
Medical and Recreational Marijuana Industry Growth
New Frontier Data projects combined U.S. sales of medical cannabis to grow 17% annually from $4.4 billion in 2018 to $13.1 billion in 2025 (4,8). In Maryland, sales doubled in the first year of legalization (2018-2019) and required a second round of business license applications for medical marijuana dispensaries, cultivators, and processors to meet consumer demand (9). Globally, BDS Analytics projects sales of recreational marijuana at $83 billion and medical marijuana at $19 billion by 2027.
CBD Industry Growth
Significant consumer interest exists in hemp-based and CBD-containing cannabis supplements. Hemp-derived CBD is now available in general retail channels outside of licensed cannabis dispensaries, including online, drug stores, natural products, beauty, convenience, grocery and pet stores. Research firm Brightfield Group projects the U.S. CBD industry will outpace the marijuana market and reach $23.7 billion in sales by 2023 (10). BDS Analytics forecasts U.S. CBD sales to reach $20 billion by 2024, accounting for nearly 44% of the $45 billion total forecasted cannabinoid market (11). Hemp-based cannabis sales of CBD-based supplements grew 332% from 2018 to 2019, with over $52 million in 2019 sales, making hemp-based cannabis supplements the top selling herbal supplement in the U.S. market (12). Current herbal supplement manufacturers are increasingly embracing CBD based cannabis products. The percent of natural product manufacturers selling such products doubled in the first six months of 2019, with 75% of the industry planning on launching new CBD-based products over the next two years (13).
Cannabis Industry Job Growth
Marijuana Business Daily’s 2019 Marijuana Business Factbook estimates the number of full-time workers in the U.S. marijuana industry was between 130,000 and 160,000 in 2018, increased to 175,000 to 215,000 in 2019, and will reach 385,000 to 475,000 workers by 2023 (9). BDS Analytics and Arcview estimate as many as 630,000 cannabis jobs by 2025 (13). Leafly’s Cannabis Job Count report suggests that the cannabis industry is among the largest job creation engines in the U.S (14).
The career opportunities vary based on the segment of the market (medical vs. recreational vs. hemp-based cannabis). However, all three segments demand similar knowledge and skill sets that are basic to the world of herbal supplements. Nationally based cannabis-specific hiring firm Vangst provides a benchmarking salary guide for working in the cannabis industry and the requirements for employment in each state (15).
Careers that graduates of the Post-Baccalaureate Certificate in Cannabis Science: Therapeutics, Product Design, and Quality Assurance may be qualified for include:
Take a look at what our Post-Baccalaureate Certificate in Cannabis Science program offers and how MUIH is the choice for you!
James Snow D.C.N
Dean of Academic Affairs
Michael (Bhodi) Tims, Ph.D.
Program Director, Herbal Product Design and Manufacture
Program Director, Cannabis Science: Therapeutics, Product Design and Quality Assurance
Rachel Voss, M.P.A.
Crystal Hoyte, M.Sc.